An Observational Study of Patients With Chronic Liver Disease

Enrolling by invitationOBSERVATIONAL
Enrollment

500,000

Participants

Timeline

Start Date

February 19, 2024

Primary Completion Date

December 31, 2037

Study Completion Date

December 31, 2037

Conditions
Chronic Liver DiseaseCirrhosis
Interventions
OTHER

Observational

Observational

Trial Locations (8)

10032

Columbia University Irving Medical Center/ New York Presbyterian Hospital, New York

19104

University of Pennsylvania, Philadelphia

20007

Georgetown Medstar Transplant Institute, Washington D.C.

28204

Atrium Health Center for Liver Disease and Transplant, Charlotte

60612

Rush University Medical Center, Chicago

75246

Baylor Scott & White Research Institute, Dallas

77021

Baylor College of Medicine, Houston

94063

Stanford Medicine, Redwood City

All Listed Sponsors
lead

Target PharmaSolutions, Inc.

INDUSTRY